Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-22T02:31:41.588Z Has data issue: false hasContentIssue false
  • English
  • Français

Endocrine stress response and inflammatory activation during CABG surgery. A randomized trial comparing remifentanil infusion to intermittent fentanyl

Published online by Cambridge University Press:  01 April 2008

M. Winterhalter ,
K. Brandl ,
N. Rahe-Meyer ,
A. Osthaus ,
H. Hecker ,
C. Hagl ,
H. A. Adams  and
S. Piepenbrock
M. Winterhalter*
Affiliation:
Hannover Medical School, Department of Anaesthesiology, Hannover, Germany
K. Brandl
Affiliation:
Hannover Medical School, Department of Anaesthesiology, Hannover, Germany
N. Rahe-Meyer
Affiliation:
Hannover Medical School, Department of Anaesthesiology, Hannover, Germany
A. Osthaus
Affiliation:
Hannover Medical School, Department of Anaesthesiology, Hannover, Germany
H. Hecker
Affiliation:
Hannover Medical School, Department of Biometry, Hannover, Germany
C. Hagl
Affiliation:
Hannover Medical School, Division of Thoracic and Cardiovascular Surgery, Hannover, Germany
H. A. Adams
Affiliation:
Hannover Medical School, Department of Anaesthesiology, Hannover, Germany
S. Piepenbrock
Affiliation:
Hannover Medical School, Department of Anaesthesiology, Hannover, Germany
*
Correspondence to: Michael Winterhalter, Department of Anaesthesiology, Hannover Medical School, Carl-NeubergStraße 1, 30625 Hannover, Germany. E-mail: [email protected]; Tel: +49-511-532-3139; Fax: +49-511-532-3642
Get access

Summary

Background and objective

Our aim was to compare a continuous infusion of remifentanil with intermittent boluses of fentanyl as regards the perioperative hormonal stress response and inflammatory activation in coronary artery bypass graft patients under sevoflurane-based anaesthesia.

Methods

In all, 42 patients undergoing coronary artery bypass grafting with cardiopulmonary bypass were prospectively randomized to a fentanyl group (n = 21, total fentanyl dose 2.6 ± 0.3 mg), or a remifentanil group (n = 21, infusion rate 0.25 μg kg−1 min−1). Haemodynamics, plasma levels of epinephrine, norepinephrine, antidiuretic hormone, adrenocorticotropic hormone, cortisol, complement activation (C3a, C5b-9), interleukin (IL)-6, IL-8 and tumour necrosis factor-α were measured at T1: baseline, T2: intubation, T3: sternotomy, T4: 30 min on cardiopulmonary bypass, T5: end of surgery and T6: 8 h postoperatively. Troponin T and creatine kinase-MB were measured postoperatively.

Results

Patients in the remifentanil group were extubated significantly earlier than fentanyl patients (240 ± 182 min vs. 418 ± 212 min, P = 0.006). Stress hormones 30 min after start of cardiopulmonary bypass showed higher values in the fentanyl group compared to the remifentanil group (antidiuretic hormone (ADH): 39.94 ± 30.98 vs. 11.7 ± 22.8 pg mL−1, P = 0.002; adrenocorticotropic hormone: 111.5 ± 116.8 vs. 21.81 ± 24.71 pg mL−1, P = 0.01; cortisol 185 ± 86 vs. 131 ± 82 ng mL−1, P = 0.04). The interleukins were significantly higher at some perioperative time points in the fentanyl group compared to the remifentanil group (tumour necrosis factor: T5: 3.57 vs. 2.37; IL-6: T5: 4.62 vs. 3.73; and IL-8: T5: 4.43 vs. 2.65 and T6: 2.61 vs. 1.13). However, cardiopulmonary bypass times and aortic cross-clamp times were longer in the fentanyl group, which may to some extent account for the differences.

Conclusions

The perioperative endocrine stress response was attenuated in patients supplemented with continuous remifentanil infusion as compared to intermittent fentanyl.

Keywords

CARDIAC SURGERYCARDIOPULMONARY BYPASSANALGESICS OPIOID, fentanyl, remifentanilMONITORING PHYSIOLOGICENDOCRINE SYSTEM, stress response
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 25 , Issue 4 , April 2008 , pp. 326 - 335
Copyright
Copyright © European Society of Anaesthesiology 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Wallace, AW. Is it time to get on the fast track or stay on the slow track? Anesthesiology 2003; 99: 774.CrossRefGoogle ScholarPubMed
2.Slogoff, S, Keats, AS. Randomized trial of primary anesthetic agents on outcome of coronary artery bypass operations. Anesthesiology 1989; 70: 179–188.CrossRefGoogle ScholarPubMed
3.Weale, NK, Rogers, CA, Cooper, R, Nolan, J, Wolf, AR. Effect of remifentanil infusion rate on stress response to the pre-bypass phase of paediatric cardiac surgery. Br J Anaesth 2004; 92: 187–194.CrossRefGoogle Scholar
4.Bell, G, Dickson, U, Arana, A, Robinson, D, Marshall, C, Morton, N. Remifentanil vs fentanyl/morphine for pain and stress control during pediatric cardiac surgery. Paediatr Anaesth 2004; 14: 856–860.CrossRefGoogle ScholarPubMed
5.Matsumoto, ED, Margulis, V, Tunc, L et al. Cytokine response to surgical stress: comparison of pure laparoscopic, hand-assisted laparoscopic, and open nephrectomy. J Endourol 2005; 19: 1140–1145.CrossRefGoogle ScholarPubMed
6.Molina, PE. Neurobiology of the stress response. Contribution of the sympathetic nervous system to the neuroimmune axis in traumatic injury. Shock 2005; 24: 3–10.CrossRefGoogle Scholar
7.Gold, SM, Mohr, DC, Huitinga, I, Flachenecker, P, Sternberg, EM, Heesen, C. The role of stress-response systems for the pathogenesis and progression of MS. Trends Immunol 2005; 26: 644–652.CrossRefGoogle ScholarPubMed
8.Rokutan, K, Morita, K, Masuda, K et al. Gene expression profiling in peripheral blood leukocytes as a new approach for assessment of human stress response. J Med Invest 2005; 52: 137–144.CrossRefGoogle ScholarPubMed
9.Brix-Christensen, V. The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children. Acta Anaesthesiol Scand 2001; 45: 671–679.CrossRefGoogle ScholarPubMed
10.Ibrahim, AE, Taraday, JK, Kharasch, ED. Bispectral index monitoring during sedation with sevoflurane, midazolam, and propofol. Anesthesiology 2001; 95: 1151–1159.CrossRefGoogle ScholarPubMed
11.Ziegler, MG, Lake, CR, Kopin, IJ. Plasma noradrenaline increases with age. Nature 1976 ; 261: 333–335.CrossRefGoogle ScholarPubMed
12.Kuchel, O, Buu, NT. Circadian variations of free and sulfoconjungated catecholamines in normal subjects. Endocr Res 1985; 11: 17–25.CrossRefGoogle ScholarPubMed
13.Saar, N, Gordon, RD. Variability of plasma catecholamine levels: age, duration of posture and time of day. Br J Clin Pharmacol 1979; 8: 353–358.CrossRefGoogle ScholarPubMed
14.El-Etr, AA, Glisson, SN, Balasaraswathi, K. Endocrine changes during anesthesia and cardiopulmonary bypass. Clev Clin Q 1981; 48: 132–138.CrossRefGoogle ScholarPubMed
15.Tan, CK, Glisson, SN, El-Etr, AA, Ramakrishnaiah, KB. Levels of circulating norepinephrine and epinephrine before, during and after cardiopulmonary bypass in man. J Thorac Cardiovasc Surg 1976; 71: 928–931.CrossRefGoogle ScholarPubMed
16.Reves, JG, Karp, RB, Buttner, EE et al. Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man. Circulation 1982; 66: 49–55.CrossRefGoogle ScholarPubMed
17.Laffey, JG, Boylan, JF, Cheng, DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002; 97: 215–252.Google ScholarPubMed
18.Rady, MY, Ryan, T, Starr, NJ. Early onset of acute pulmonary dysfunction after cardiovascular surgery: risk factors and clinical outcome. Crit Care Med 1997; 25: 1831–1839.CrossRefGoogle ScholarPubMed
19.Besedovsky, HO, del Rey, A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 1996; 17: 64–102.CrossRefGoogle Scholar
20.Wan, S, LeClerc, JL, Vincent, JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 676–692.CrossRefGoogle ScholarPubMed
21.Ito, H, Hamano, K, Gohra, H et al. Relationship between respiratory distress and cytokine response after cardiopulmonary bypass. Surg Today 1997; 27: 220–225.CrossRefGoogle ScholarPubMed
22.Guggenberger, H, Schroeder, TH, Vonthein, R, Dieterich, HJ, Shernan, SK, Eltzschig, HK. Remifentanil or sufentanil for coronary surgery: comparison of postoperative respiratory impairment. Eur J Anaesthesiol 2006; 23: 832–840.CrossRefGoogle ScholarPubMed
23.Yokoyama, M, Itano, Y, Katayama, H et al. The effects of continuous epidural anesthesia and analgesia on stress response and immune function in patients undergoing radical esophagectomy. Anesth Analg 2005; 101: 1521–1527.CrossRefGoogle ScholarPubMed
24.Soulika, AM, Khan, MM, Hattori, T et al. Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons. Clin Immunol 2000; 96: 212–221.CrossRefGoogle ScholarPubMed
25.Seghaye, MC, Duchateau, J, Grabitz, RG et al. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg 1993; 106: 978–987.CrossRefGoogle ScholarPubMed
26.Kirklin, JK, Westaby, S, Blackstone, EH, Kirklin, JW, Chenoweth, DE, Pacifico, AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845–857.CrossRefGoogle ScholarPubMed
27.Fitch, JC, Rollins, S, Matis, L et al. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Circulation 1999; 100: 2499–2506.CrossRefGoogle ScholarPubMed
28.Voss, EM, Sharkey, SW, Gernet, AE et al. Human and canine cardiac troponin T and creatine kinase-MB distribution in normal and diseased myocardium. Arch Pathol Lab Med 1995; 119: 799–806.Google ScholarPubMed
29.Wan, S, Marchant, A, DeSmet, JM et al. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg 1996; 111: 469–477.CrossRefGoogle ScholarPubMed